Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

The Binding Site Group

US

Last updated May 24, 2026

Part of The Binding Site Group Ltd

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
—

Catalogue (283)

Page 1 of 6
DeviceModel / ReferenceRegistriesClassStatus
Human IgG1 Subclass Single Dilution BINDARID™ Kits RN106.3
FDA UDI
Class IIActive
Hevylite IgM Kappa Kit for Siemens BNII NK625.T.A
FDA UDI
Class IIActive
Optilite Alpha-1-Acid Glycoprotein Kit NK063.OPT.A
FDA UDI
Class IActive
Human IgG Subclass Single Dilution BINDARID™ Kit - Bulk Kit RK021
FDA UDI
Class IIActive
Human Caeruloplasmin Kit for use on SPAPLUS NK045.S
FDA UDI
Class IIUnknown
Freelite® Human Kappa Free Kit for use on the Beckman AU® series LK016.AU
FDA UDI
Class IIActive
Diptheria Toxoid IgG Low Control EA070.A
FDA UDI
Class IActive
Freelite Kappa Free Panel Sample Set BP233
FDA UDI
Class IActive
Human IgG2 Subclass Liquid Reagent Kit for use on the Siemens BN™II - Bulk Kit NK007.2TB
FDA UDI
Class IIActive
Optilite Alpha-2-macroglobulin Kit NK039.OPT.A
FDA UDI
Class IIActive
Antistreptolysin O AMR Fluid BP529
FDA UDI
Class IActive
Human IgG2 SPA PLUS Bulk Kit NK007.10S.A
FDA UDI
Class IIActive
MININEPH™ Human IgA Kit ZK010.R
FDA UDI
N/AUnknown
Human Haptoglobin BINDARID™ Radial Immunodiffusion Kit RN058.3
FDA UDI
Class IIActive
Human IgA1 Kit SPAplus NK087.S
FDA UDI
Class IIUnknown
A1 Acid Glycoprotein AMR Fluid BP527
FDA UDI
Class IActive
Human IgG2 Subclass Single Dilution BINDARID™ Kits RN107.3
FDA UDI
Class IIActive
MININEPH™ Human C4 Kit ZK025.R
FDA UDI
N/AUnknown
Human IgG2 Subclass Liquid Reagent Kit for use on the Siemens BNII NK007.TB
FDA UDI
Class IIActive
Human IgG - ‘NL’ BINDARID™ Radial Immunodiffusion Kit RN004.3
FDA UDI
Class IIUnknown
Human Beta-2 Microglobulin Control Pack for use on the SPAPLUS® NQ043.S
FDA UDI
Class IUnknown
Hevylite Human IgG Kappa Kit for use on the SPAPLUS NK621.S.A
FDA UDI
Class IIActive
Human IgA kit for use on SPAPLUS- Bulk Kit NK010.10S
FDA UDI
Class IIActive
Optilite Freelite Lambda Kit LK018.OPT.A
FDA UDI
Class IIActive
Optilite Cystatin C Kit LK048.OPT.A
FDA UDI
Class IIActive
Freelite Lambda Free Panel Sample Set BP234
FDA UDI
Class IActive
Optilite Rheumatoid Factor Kit LK151.OPT.A
FDA UDI
Class IIActive
Human IgG3 Subclass Single Dilution BINDARID™ Kits RN109.3
FDA UDI
Class IIActive
C-Reactive Protein Kit for SPAPLUS NK044.S.A
FDA UDI
Class IIUnknown
Hevylite Human IgG Lambda Kit for use on the SPAPLUS NK622.S.A
FDA UDI
Class IIActive
Optilite High Sensitivity C-Reactive Protein Kit LK044.L.OPT.A
FDA UDI
Class IIActive
Optilite C-Reactive Protein Reagent NK044.OPT.A
FDA UDI
Class IIActive
Tetanus Toxoid Coated EIA Plates EA114.A
FDA UDI
Class IActive
Human C4 Control Pack for use on the SPAPLUS® NQ025.S
FDA UDI
Class IUnknown
Human IgG4 SPA PLUS Bulk Kit LK009.10S.A
FDA UDI
Class IIActive
Human Prealbumin Kit for use on SPAPLUS NK066.S
FDA UDI
Class IUnknown
Sheep Anti-Human IgE Immunofixation Grade PX014
FDA UDI
Class IIActive
Anti-Human IgG - Particle - ASR pack MA004
FDA UDI
Class IActive
Optilite® C1 Inactivator Control Pack NQ019.OPT
FDA UDI
Class IActive
Human Transferrin Kit for use on SPAPLUS NK070.S
FDA UDI
N/AUnknown
Freelite® Human Kappa Free Kit for use on the SPAPLUS LK016.S
FDA UDI
Class IIUnknown
Optilite® Rheumatoid Factor Control Pack NQ151.OPT
FDA UDI
Class IActive
Optilite IgD Kit LK013.OPT.A
FDA UDI
Class IIActive
Human Microalbumin Kit for use on SPAPLUS NK032.U.S.A
FDA UDI
Class IIActive
Human Beta-2 Microglobulin Latex Kit for use on the Siemens BN™II LK043.T
FDA UDI
Class IIUnknown
Freelite® Human Kappa Free Kit for use on the Beckman Coulter IMMAGE®/IMMAGE®800 LK016.IM
FDA UDI
Class IIActive
Human Albumin NL BINDARID™ Radial Immunodiffusion Kit RN032.3
FDA UDI
Class IIActive
MININEPH™ Human IgG Kit ZK004.R
FDA UDI
N/AUnknown
Total Haemolytic Complement RC001.3
FDA UDI
Class IIActive
Human C-Reactive Protein ‘EL’ NANORID Radial Immunodiffusion Kit GT044.3
FDA UDI
N/AActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (28)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Oct 15, 2021Z-0274-2022—terminated

Due to calibration curves producing a higher activity than routinely expected and that there may be a decrease in separation between calibrator point 5 and calibrator point 6, which can be exacerbated with calibrator 6 activity reaches the optical ceiling of the SPA+ analyzer.

May 20, 2021Z-2030-2021—terminated

The high and low level "Quality Controls" demonstrate a positive bias of approximately 10% compared to assigned values.

Nov 18, 2020Z-0943-2021—terminated

Due to customer complaints of positive bias impacting quality control. The high and low level controls are demonstrating a positive bias compared to assigned values.

Apr 9, 2020Z-2071-2020—terminated

A software issue that may affect the analyzer's result accuracy.

Nov 6, 2019Z-1500-2020—terminated

It has been identified that the rheumatoid factor (RF) calibrator values over recover in comparison to the reference material RF serum. This could result in reporting falsely abnormal results which may lead to unnecessary additional serological testing.

Oct 7, 2019Z-2110-2020—terminated

Assigned Rheumatoid Factor (RF) calibrator value for calibrator component included in kit used to aid in the diagnosis of rheumatoid arthritis over recovers by 7% in comparison to the reference material RF serum. This could result in reporting abnormal (false positive) results, which may lead to unnecessary additional serological testing and a delay in treatment.

Jul 29, 2019Z-1327-2020—terminated

There is a potential that users may experience difficulty validating the calibration of the kit. This is indicated by kit control values reporting outside the specified ranges. This could result in potential false patient results which could cause a delay until repeat testing is performed.

Apr 25, 2019Z-1619-2020—terminated

A reagent in C reactive protein kits is not performing to specification and samples with known concentrations less-than-or-equal to 10 mg/L may be affected

Feb 19, 2019Z-0671-2020—terminated

Deterioration of C-reactive protein (CRP) reagent in Optilite C-Reactive Protein Kits

Nov 6, 2018Z-0604-2019—terminated

Firm is offering advice to customers experiencing challenges when validating the calibration curve of the IgM kits. This is indicated by kit control values reporting outside the specified ranges.

Aug 12, 2018Z-1469-2020—terminated

A deterioration of performance was identified with influenza type B Enzyme Immunoassay Kits with findings of a positive bias with kit controls. Patient sample results may be affected with falsely elevated results incorrectly indicating a protective level of anti-Hib antibody in the assessment of immunodeficiency.

Jul 25, 2018Z-0477-2019—terminated

After running the calibration curve, the recovery of the IgM kit control results decrease demonstrating a reduction in accuracy within the same day; control results may be out of range one day after running the assay calibration curve. Samples have been shown to be similarly affected.

Mar 9, 2018Z-1301-2018—terminated

The product is not meeting the antigen excess protection claim of up to 760mg/L, as stated in the Instructions for Use.

Jan 4, 2018Z-0553-2018—terminated

The low and high controls for the product are returning results above the assigned values.

Aug 23, 2017Z-0002-2018—terminated

The high control for the kit is recovering low and may be out of range for assigned values.

Dec 23, 2016Z-1089-2017—terminated

A change to the lower end of the measuring range and product insert did not reflect the change.The measuring range provided in instrument parameters is correct but contradicts the information provided in the product insert

Oct 28, 2016Z-1053-2017—terminated

A change in the calibration curve causing an increase in false prozone flags.

Jul 5, 2016Z-1043-2017—terminated

Batch numbers listed are reporting Lambda Free Light Chain results >114mg/L that are on average 33% lower than other Optilite Lambda Freelite batches. Therefore users moving to this batch will see results >114mg/L giving lower results and conversely when switching to the next batch results will be seen to shift upwards.

May 13, 2015Z-1018-2017—terminated

Potential risk of the Optilite lid/cover falling suddenly and causing injury when not placed in the fully open position.

Sep 11, 2014Z-1068-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Sep 11, 2014Z-1071-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Sep 11, 2014Z-1073-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Sep 11, 2014Z-1072-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Sep 11, 2014Z-1067-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Sep 11, 2014Z-1070-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Sep 11, 2014Z-1069-2017—terminated

Customer complaints identified that samples containing extremely high IgG4 levels exhibit antigen excess and will yield spuriously low IgG4 results.

Nov 28, 2012Z-1050-2017—terminated

Calibration curve activity has increased over time in the kit lots listed.

Oct 9, 2012Z-1055-2017—terminated

If a control ring is marked after reading, the software will not flag results that are out of the specified QC range.